Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly

BACKGROUND: Histone deacetylase (HDAC) inhibitors are currently undergoing clinical evaluation as anti-cancer agents. Dietary constituents share certain properties of HDAC inhibitor drugs, including the ability to induce global histone acetylation, turn-on epigenetically-silenced genes, and trigger...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Praveen, Delage, Barbara, Dashwood, W Mohaiza, Yu, Tian-Wei, Wuth, Bradyn, Williams, David E, Ho, Emily, Dashwood, Roderick H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127849/
https://www.ncbi.nlm.nih.gov/pubmed/21624135
http://dx.doi.org/10.1186/1476-4598-10-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127849/
https://www.ncbi.nlm.nih.gov/pubmed/21624135
http://dx.doi.org/10.1186/1476-4598-10-68

Ejemplares similares